HMS TECHNOLOGIES, INC.

HMS Technologies, Inc. specializes in the manufacturing and supply of surgical appliances and medical devices, delivering critical healthcare products under government procurement programs. Their technical expertise lies in producing compliant, high-integrity medical supplies that meet stringent regulatory standards for clinical use, including sterile packaging, material traceability, and quality control protocols aligned with FDA and ISO requirements. The company’s key differentiator is its ability to reliably fulfill time-sensitive medical supply contracts, ensuring uninterrupted availability of essential surgical instruments and disposable medical products in high-demand healthcare environments. Their operational focus emphasizes precision manufacturing, inventory agility, and adherence to federal procurement timelines for mission-critical medical assets. The contractor has demonstrated direct experience supporting the Department of Health and Human Services, providing medical supply chain solutions that support public health initiatives and federal healthcare delivery systems. Their engagement with HHS reflects a focused relationship centered on sustaining operational readiness through the timely delivery of surgical and clinical consumables, likely supporting facilities under CDC, NIH, or CMS oversight. HMS Technologies operates within the surgical appliance and supplies manufacturing sector (NAICS 339113), a niche domain requiring validated production processes, controlled environments, and regulatory documentation for medical devices. This vertical specialization positions them as a supplier of Class I and II medical instruments, with an emphasis on single-use, non-implantable surgical tools and related consumables. Their market positioning is that of a reliable, low-volume manufacturer serving federal health agencies with targeted, high-reliability product lines. The company’s structure, size, and certifications are not disclosed in available records, and no government certifications are listed. Geographic presence and federal market footprint cannot be determined from the provided data, but their contract activity indicates a capacity to serve national-level healthcare supply needs with a focused, product-centric approach.